MSU’s Cisplatin Discovery Continues to Save Lives and Fuel Innovation (MSU Research Foundation news release) (2025)

News Report · Michigan State University Research Foundation · September 18, 2025

Michigan State University Research Foundation, 2025-09-18: MSU Research Foundation statement that cisplatin licensing royalties have produced more than $400 million, with royalties from cisplatin and its derivative carboplatin managed by the Foundation.

Licensing royalties from the life-saving cisplatin treatment have generated more than $400 million for research, startup investment, and innovation programs led by the MSU Research Foundation.

HTML page, unpaginated

Michigan State University Research Foundation, 2025-09-18: MSU Research Foundation statement that cisplatin licensing royalties have produced more than $400 million, with royalties from cisplatin and its derivative carboplatin managed by the Foundation. Funder/conflicts: the publisher is the royalty beneficiary; this is a self-interested institutional source and the figure is unaudited in the document. Maker: n/a. Comparator: n/a. The page gives no year-by-year royalty schedule and no audited financial statement; MSU's Form 990/annual report would be needed to independently corroborate the $400 million. Study type: news.